Skip to main
BNGO
BNGO logo

Bionano Genomics (BNGO) P/E Ratio

P/E Ratio as of Sep 8, 2025: -0.09

Average-0.0805
Median-0.0850
Minimum-0.0900
Maximum-0.0500
-0.09
Past Month-0.04 (80.00%)
The P/E ratio for Bionano Genomics (BNGO) is -0.09 as of Sep 8, 2025. This represents a increase of 12.50% compared to its 12-month average P/E ratio of -0.08. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Bionano Genomics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Bionano Genomics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Bionano Genomics to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Bionano Genomics (BNGO) P/E Ratio Historic Data

DateStock priceP/E ratio
Sep 2, 2025$4.09-0.09
Aug 1, 2025$2.95-0.05
Jul 1, 2025$3.30-0.06
Jun 2, 2025$3.68-0.06
May 1, 2025$4.00-0.04
Apr 1, 2025$3.10-0.03
Mar 3, 2025$4.00-0.03
Feb 3, 2025$5.30-0.04
Jan 2, 2025$15.318-0.17

Bionano Genomics (BNGO) End of Year P/E Ratio

DateP/E ratioChange
2025-0.09-52.63%
2024-0.19-29.63%
2023-0.27-92.44%
2022-3.57-68.90%
2021-11.48+96.58%
2020-5.84

FAQs About Bionano Genomics (BNGO) P/E ratio

The latest P/E ratio of Bionano Genomics (BNGO) is -0.09, as of Sep 8, 2025. This is calculated based on its current stock price and earnings per share (EPS).

Bionano Genomics’s last 12-month average P/E ratio is -0.08, compared to its current P/E ratio of -0.09. This reflects a increase of 12.50%.

Bionano Genomics’s current P/E ratio of -0.09 is higher than its last 12-month average P/E of -0.08. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Bionano Genomics’s average P/E ratio over the last 3 years is -1.03. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Bionano Genomics’s average P/E ratio over the last 5 years is -6.08. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Bionano Genomics (BNGO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.